Oral delivery oftransfected sequentially with two copies of the VP2 gene induces immunity against infectious bursal disease virus in chickens.

Abstract

Chicken coccidiosis caused byspp. can occur on almost all poultry farms, causing huge economic losses to the industry. Genetically manipulatedparasites as a vaccine vector to deliver viral antigens have been reported. In our preliminary study, transgenicexpressing a VP2 gene (Ea-VP2) of the infectious bursal disease virus (IBDV) demonstrated partial protection against IBDV infection. To enhance immune responses, we aimed to increase the VP2 gene copy number in transgenic. In this study, we used a novel plasmid vector carrying a VP2 gene fused with three flag tags and a red fluorescent reporter gene (mCherry). The vector was introduced into Ea-VP2 sporozoites through nucleofection, leading to the generation of Ea-2VP2. Subsequent analysis revealed a notable escalation in the fluorescent rate, increasing from 0.11 to 95.1% following four consecutive passages facilitated by fluorescent-activated cell sorting. Verification via PCR, Western blot, and immunofluorescence confirmed the successful construction of the Ea-2VP2 population. Despite lower fecundity compared to wild-type, Ea-2VP2 maintained immunogenicity. Our research effectively created a transgenicstrain transfected sequentially with two copies of the VP2 gene from IBDV. This modification resulted in an increased humoral immune response after primary immunization in chickens. Additionally, it demonstrated a degree of protection within the bursa against IBDV infection. Future studies will focus on further enhancing immune response levels.